Translating Phase II success into Phase III readiness takes more than scale
The move from Phase II to Phase III is often treated as a clinical milestone, when it is actually a development-wide transition.
The move from Phase II to Phase III is often treated as a clinical milestone, when it is actually a development-wide transition.
WHO Technical Advisory Group recommends mRNA-1469 for inclusion in efficacy study following encouraging Phase 1 clinical results
HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-...
Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in peop...
~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~
A new €8 million (about $8.8 million) European research project will support a Phase 2 trial of HER-096, Herantis Pharma’s experimental therapy designed to protect nerve cells and...
The first patient has been dosed in Mission Therapeutics’ Phase 1b clinical trial of MTX325, an oral treatment for Parkinson’s disease. With several locations open in the U.K., Fra...
IGC Pharma completes Phase 2 CALMA enrollment with 168 participants randomized, advancing toward database lock and expected Q4 2026 topline results.
Final participant completes dosing in 170-participant trial; topline results anticipated during the December 2026/January 2027 timeframe
The first patient has been dosed in a Phase 2a clinical trial evaluating Jotrol, an investigational oral formulation of resveratrol that Jupiter Neurosciences is developing for Par...
This morning, Helus Pharma (formerly Cybin) announced a positive topline readout from its first Phase 3 study of HLP003, a deuterated psilocin analog, for the adjunctive treatment...
Novartis is testing an experimental pill that could help protect people with food allergies from accidental exposure. The post Novartis Launches Phase III Trial of Pill That Could...
Scientists in the southern Ugandan city of Masaka are conducting a phase I trial of a candidate vaccine against the deadly Ebola Bundibugyo virus disease (BDBV), a strain for which...
Phase One trial involves an experimental vaccine candidate known as ChAdOx1 BDBV. It's being conducted by Ugandan researchers alongside colleagues from London and University of Oxf...
The injectable treatment showed a 30-percentage-point advantage over placebo in submental fat responder rates after a single treatment cycle, supporting plans for a regulatory fili...
Explore the four phases of clinical trials, from initial safety testing to large-scale studies evaluating treatment effectiveness and long-term risks. The post How Clinical Trials...
An Oxford-developed vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus caused by Bundibugyo virus (BDBV), entered a Phase I clinical study in Uganda on 6t...
Roche reported the drug sefaxersen achieved statistically significant and clinically meaningful results in a Phase 3 test in immunoglobulin A nephropathy, or IgAN. This antisense o...
The final participant has completed their last visit in the COMP006 study at Oxford, marking the end of the active delivery phase at the NIHR Clinical Research Facility (CRF).
Vertero Therapeutics has completed patient enrollment in a Phase 1b clinical trial testing VT-5006, an experimental treatment designed to target gut-related mechanisms believed to...
ACI-7104, AC Immune’s experimental vaccine for early Parkinson’s disease, was generally safe and triggered an immune response against aggregated alpha-synuclein, according to resul...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.